Search results
PNC Financial Services Group Inc. Buys 4,745 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 13 hours agoPNC Financial Services Group Inc. boosted its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.3% during the fourth quarter, according ...
Investing in Gilead Sciences, Inc.
Knox Daily· 15 hours agoGilead Sciences, Inc.’s recently made public that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for ...
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock
Zacks via Yahoo Finance· 9 hours agoGilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you...
Gilead (GILD) Announces Positive Interim Results on PBC Drug
Zacks via Yahoo Finance· 1 day agoGilead Sciences (GILD) experimental candidate, seladelpar, demonstrates significant improvements in...
Gilead's Recently Acquired Liver Disease Candidate Shows Improvements In Disease Progression And...
Benzinga via Yahoo Finance· 1 day agoSaturday, Gilead Sciences Inc (NASDAQ:GILD), following the recent acquisition of CymaBay...
Gilead Sciences: Native Health Navigator Program Connects
3BL CSRwire· 6 days agoOlivia Sloan was pursuing a career in health policy and research when her father was diagnosed with...
Positive trial outcomes lead BMO to maintain outperform rating on Gilead stock By Investing.com
Investing.com· 1 day agoOn Monday, BMO (TSX:BMO) Capital maintained its Outperform rating on Gilead Sciences (NASDAQ:GILD)...
Gilead's new liver disease med continues to deliver the goods ahead of FDA verdict
FierceBiotech· 1 day agoThree months after spending $4.3 billion on CymaBay Therapeutics for its primary biliary cholangitis...
If You Invested $10K in These Companies With Dave Ramsey, You’d Be Nearly $16K Richer
GOBankingRates via Yahoo Finance· 2 hours agoUnlike many finance experts and investors, Dave Ramsey does not recommend investing in S&P 500...
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and...
Morningstar· 3 days agoInvestigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis - 70% of Patients Receiving Seladelpar 10mg Achieved the Clinically Meaningful Composite Endpoint and 37
